ASCO GU: In Prostate Cancer, Shorter Androgen Blockade Just As Effective

Physicians treating men with high-risk prostate cancer can safely reduce the duration of androgen blockade given in combination with pelvic radiation from 36 months to 18 months without compromising outcomes, including survival.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news